The popularity of Viagra initially sparked a period of growth for major pharmaceutical companies, but recent shifts present a murky picture for investors. Generic competitors are reducing revenue, and persistent legal https://jaysonmajf315015.blog4youth.com/41699132/the-blue-pill-and-big-pharma-a-volatile-play